{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/417320357"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Once they had figured out the molecular pathway responsible for poor wound healing in diabetic tissue, the researchers realized that deferoxamine ??? an off-patent drug that binds to iron and removes it from the body ??? might help to short-circuit this pathway. (Deferoxamine has been used for decades to treat diseases such as thalassemia in which toxic levels of iron accumulate in tissues.)" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "yu.edu" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/139003757"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/417320357"] } } }
